The American Academy of Sleep Medicine (AASM) has published suggested guidelines for the use of Home Sleep Testing (HST) in the diagnosis of Obstructive Sleep Apnea (OSA). They recommend that HST be used only in the context of a Comprehensive Sleep Evaluation and for the following patients:
- Patients with a high pre-test probability of moderate to severe OSA. Patients with no significant co-morbid medical condition.
- Examples of co-morbid conditions include moderate-severe pulmonary diseases (cystic fibrosis, pulmonary fibrosis, active asthma, COPD), congestive heart failure and neuromuscular diseases (ALS, multiple sclerosis, Parkinson's disease).
- Patients suspected of having no co-morbid sleep disorder other than OSA.
- Patients unable to be studied in a sleep laboratory.
- To monitor response to non-CPAP treatments after the diagnosis has already been made.